The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer
NCT05352217 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2024-04-22
Summary
The study is designed as an observational cohort study, aiming to evaluate, whether a structured recording of symptoms by a mobile app contributes insight in the follow-up modalities of ovarian cancer patients.
Conditions
- Patient Reported Outcome Measures
- Ovarian Neoplasms
Interventions
- DEVICE
-
Mobile app ovarian cancer followup (ePRO)
The study is designed as an observational cohort study, aiming to evaluate, whether a structured recording of symptoms by a mobile app contributes insight in the follow-up modalities of ovarian cancer patients.
Sponsors & Collaborators
-
Klinik Hirslanden, Zurich
collaborator OTHER -
Manja Gideon Foundation
collaborator UNKNOWN -
Stiftung Swiss Tumor Institute
lead OTHER
Principal Investigators
-
Pius Wyss, Prof.Dr.med · Swiss Tumor Institue
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-13
- Primary Completion
- 2023-11-13
- Completion
- 2023-11-13
Countries
- Switzerland
Study Locations
More Related Trials
-
Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer
NCT04971421 ·Status: UNKNOWN
-
Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer
NCT01175967 ·Status: TERMINATED
-
Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test
NCT04812938 ·Status: UNKNOWN
-
ChemoFx® PRO - A Post-Market Data Collection Study
NCT00669422 ·Status: TERMINATED
-
Impact of Gonadotoxic Therapies on Fertility
NCT05885048 ·Status: RECRUITING
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
NCT05731661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia
NCT04001023 ·Status: RECRUITING ·Phase: NA
-
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
NCT04675320 ·Status: UNKNOWN
-
Spatial Radiogenomics of Ovarian Cancer
NCT06324175 ·Status: RECRUITING
-
Individualized Precision Treatment Based on Ovarian Cancer Organoid Model
NCT05813509 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
NCT00712452 ·Status: TERMINATED ·Phase: NA
-
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NCT06611072 ·Status: RECRUITING ·Phase: NA
-
The Immune Landscape of Epithelial Ovarian Cancer
NCT05984875 ·Status: RECRUITING
-
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
NCT04092270 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02627443 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer
NCT04718376 ·Status: TERMINATED ·Phase: PHASE1
-
Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO
NCT06917469 ·Status: COMPLETED
-
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
NCT05574673 ·Status: RECRUITING
-
Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan
NCT00720096 ·Status: TERMINATED ·Phase: NA
-
OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
NCT06466382 ·Status: RECRUITING ·Phase: NA
-
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
NCT06969833 ·Status: RECRUITING ·Phase: NA
-
Prognostic and Predictive Biomarkers in Ovarian Cancers
NCT03010124 ·Status: RECRUITING ·Phase: NA
-
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00801320 ·Status: COMPLETED ·Phase: NA
-
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
NCT00968799 ·Status: TERMINATED ·Phase: NA